The proportion of patients with 3 lines of vision is the more important endpoint.
I know of Ophthotech having some vision improvement in a randomized trial vs lucentis. Are the other drugs you mention in placebo controlled trials or open label?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.